These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 36503459)

  • 1. Phage Therapy as a Protective Tool Against Pathogenic Bacteria: How Far We Are?
    Singh K; Biswas A; Chakrabarti AK; Dutta S
    Curr Pharm Biotechnol; 2023; 24(10):1277-1290. PubMed ID: 36503459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacteriophage genome engineering for phage therapy to combat bacterial antimicrobial resistance as an alternative to antibiotics.
    Usman SS; Uba AI; Christina E
    Mol Biol Rep; 2023 Aug; 50(8):7055-7067. PubMed ID: 37392288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacteriophage therapy against ESKAPE bacterial pathogens: Current status, strategies, challenges, and future scope.
    Kulshrestha M; Tiwari M; Tiwari V
    Microb Pathog; 2024 Jan; 186():106467. PubMed ID: 38036110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacteriophage-based approach for treatment of urinary tract infections: a quick outlook.
    Grygorcewicz B; Gliźniewicz M; Jabłońska J; Augustyniak A; Olszewska P; Wojciuk B; Miłek D; Serwin N; Czajkowski A; Cecerska-Heryć E; Rakoczy R; Cymbaluk-Płoska A
    APMIS; 2024 Feb; 132(2):81-93. PubMed ID: 38031200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacteriophage Therapy for Critical and High-Priority Antibiotic-Resistant Bacteria and Phage Cocktail-Antibiotic Formulation Perspective.
    Kaur G; Agarwal R; Sharma RK
    Food Environ Virol; 2021 Dec; 13(4):433-446. PubMed ID: 34120319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of Phage Therapy and Corresponding Optimization Strategies: A Review.
    Lin J; Du F; Long M; Li P
    Molecules; 2022 Mar; 27(6):. PubMed ID: 35335222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming Bacteriophage Resistance in Phage Therapy.
    Laanto E
    Methods Mol Biol; 2024; 2738():401-410. PubMed ID: 37966611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations among Antibiotic and Phage Resistance Phenotypes in Natural and Clinical
    Allen RC; Pfrunder-Cardozo KR; Meinel D; Egli A; Hall AR
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bacteriophage Therapy of Urological Infections].
    Perepanova TS; Merinov DS; Kazachenko AV; Khazan PL; Malova YA
    Urologiia; 2020 Nov; (5):106-114. PubMed ID: 33185357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going?
    Luong T; Salabarria AC; Roach DR
    Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophages as Therapeutic Agents: Alternatives to Antibiotics.
    Samir S
    Recent Pat Biotechnol; 2021; 15(1):25-33. PubMed ID: 33475081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriophages as Therapeutic and Prophylactic Means: Summary of the Soviet and Post Soviet Experiences.
    Chanishvili N
    Curr Drug Deliv; 2016; 13(3):309-23. PubMed ID: 27090515
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developing Phage Therapy That Overcomes the Evolution of Bacterial Resistance.
    Oromí-Bosch A; Antani JD; Turner PE
    Annu Rev Virol; 2023 Sep; 10(1):503-524. PubMed ID: 37268007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacteriophage as an antibacterial agent: a patent perspective.
    Pathak-Vaidya P; Sharma S; Telang M
    Future Microbiol; 2021 Nov; 16():1327-1339. PubMed ID: 34755539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacteriophage Therapy: Clinical Trials and Regulatory Hurdles.
    Furfaro LL; Payne MS; Chang BJ
    Front Cell Infect Microbiol; 2018; 8():376. PubMed ID: 30406049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Clinical Landscape and Global Potential of Bacteriophage Therapy.
    Hitchcock NM; Devequi Gomes Nunes D; Shiach J; Valeria Saraiva Hodel K; Dantas Viana Barbosa J; Alencar Pereira Rodrigues L; Coler BS; Botelho Pereira Soares M; Badaró R
    Viruses; 2023 Apr; 15(4):. PubMed ID: 37113000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacteriophage therapy: an overview and the position of Italian Society of Infectious and Tropical Diseases.
    Cesta N; Di Luca M; Corbellino M; Tavio M; Galli M; Andreoni M
    Infez Med; 2020 Sep; 28(3):322-331. PubMed ID: 32920567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteriophages, phage endolysins and antimicrobial peptides - the possibilities for their common use to combat infections and in the design of new drugs.
    Mirski T; Lidia M; Nakonieczna A; Gryko R
    Ann Agric Environ Med; 2019 Jun; 26(2):203-209. PubMed ID: 31232046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage therapy: a reappraisal of bacteriophages as antibiotics.
    Inal JM
    Arch Immunol Ther Exp (Warsz); 2003; 51(4):237-44. PubMed ID: 12956433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.